FDA approves Vizzโขโthe first once-daily eye drop for presbyopia. Fast onset (30 mins), long-lasting (10 hrs), no myopic shift. Backed by CLARITY trials with 96% near-vision improvement. Designed for active lifestyles.
#EyeHealth #VizzDrop
CardiologyOphthalmologyTRIALS < class="penci-entry-title entry-title grid-title penci_grid_title">FDA Approves Lenz Therapeutics’ Vizzโข for Presbyopia Treatment